Skip to main content
Erschienen in: Supportive Care in Cancer 4/2013

01.04.2013 | Original Article

When clinicians telling the truth is de facto discouraged, what is the family’s attitude towards disclosing to a relative their cancer diagnosis?

verfasst von: Dian-can Wang, Xin Peng, Chuan-bin Guo, Yan-jie Su

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study evaluated the attitudes of cancer patients’ family members regarding disclosure of a cancer diagnosis to the patient and justifications for their attitudes.

Methods

Family members were invited to complete a questionnaire to evaluate their attitudes towards disclosure of a cancer diagnosis to a relative as well as reasons for their point of view. Data were analyzed to evaluate factors influencing attitudes.

Results

One hundred eighty-six completed surveys were returned. Of them, 44.1 % (82/186) indicated that the patient should be informed of the diagnosis, and 55.9 % (104/186) stated emphatically that the patient should not be told the truth. The main reason given for concealing the truth was fear that awareness of a cancer diagnosis might cause psychological morbidity. The justifications for disclosing the bad news were as follows: (1) obtaining the patient’s cooperation during treatment, (2) the impossibility of concealment, and (3) believing the patient was psychologically strong enough to accept the truth. Patients’ educational status and awareness of disease as well as family members’ age were the factors that influenced attitudes toward disclosure.

Conclusions

Telling the truth to a cancer patient is often de facto discouraged in clinicians. Family members often support nondisclosure, especially when they have experience with a relative who is unaware of the truth. The education level of family members does not appear to influence decisions regarding disclosure. These findings can be helpful in the development of policies and/or programs to assist medical professionals and family members engage in truthful disclosure to a patient who has cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mystakidou K, Parpa E, Tsilika E et al (2004) Cancer information disclosure in different cultural contexts. Support Care Cancer 12:147–154PubMedCrossRef Mystakidou K, Parpa E, Tsilika E et al (2004) Cancer information disclosure in different cultural contexts. Support Care Cancer 12:147–154PubMedCrossRef
2.
Zurück zum Zitat Hallenbeck J, Arnold R (2007) A request for nondisclosure: don’t tell mother. J Clin Oncol 25:5030–5034PubMedCrossRef Hallenbeck J, Arnold R (2007) A request for nondisclosure: don’t tell mother. J Clin Oncol 25:5030–5034PubMedCrossRef
3.
Zurück zum Zitat Javad S, A. T-K, S.H. Y et al. (2007) Truth-telling to cancer patients from relatives’ point of view: a multi-centre study in Iran. Austral-Asian J Cancer 6:213–217 Javad S, A. T-K, S.H. Y et al. (2007) Truth-telling to cancer patients from relatives’ point of view: a multi-centre study in Iran. Austral-Asian J Cancer 6:213–217
4.
Zurück zum Zitat McCabe MS, Wood WA, Goldberg RM (2010) When the family requests withholding the diagnosis: who owns the truth? J Oncol Practice 6:94–96CrossRef McCabe MS, Wood WA, Goldberg RM (2010) When the family requests withholding the diagnosis: who owns the truth? J Oncol Practice 6:94–96CrossRef
5.
Zurück zum Zitat Capozzi JD, Rhodes R (2006) A family’s request for deception. J Bone Joint Surg Am 88A:906–908CrossRef Capozzi JD, Rhodes R (2006) A family’s request for deception. J Bone Joint Surg Am 88A:906–908CrossRef
6.
Zurück zum Zitat Yun YH, Lee CG, Kim SY et al (2004) The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol 22:307–314PubMedCrossRef Yun YH, Lee CG, Kim SY et al (2004) The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol 22:307–314PubMedCrossRef
7.
Zurück zum Zitat Ozdogan M, Samur M, Bozcuk HS et al (2004) “Do not tell”: what factors affect relatives’ attitudes to honest disclosure of diagnosis to cancer patients? Support Care Cancer 12:497–502PubMedCrossRef Ozdogan M, Samur M, Bozcuk HS et al (2004) “Do not tell”: what factors affect relatives’ attitudes to honest disclosure of diagnosis to cancer patients? Support Care Cancer 12:497–502PubMedCrossRef
8.
Zurück zum Zitat Jiang Y, Liu C, Li JY et al (2007) Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. Psycho-Oncol 16:928–936CrossRef Jiang Y, Liu C, Li JY et al (2007) Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. Psycho-Oncol 16:928–936CrossRef
9.
Zurück zum Zitat Paul CL, Clinton-McHarg T, Sanson-Fisher RW et al (2009) Are we there yet? The state of the evidence base for guidelines on breaking bad news to cancer patients. Eur J Cancer 45:2960–2966PubMedCrossRef Paul CL, Clinton-McHarg T, Sanson-Fisher RW et al (2009) Are we there yet? The state of the evidence base for guidelines on breaking bad news to cancer patients. Eur J Cancer 45:2960–2966PubMedCrossRef
10.
Zurück zum Zitat Fujimori M, Uchitomi Y (2009) Preferences of cancer patients regarding communication of bad news: a systematic literature review. Jpn J Clin Oncol 39:201–216PubMedCrossRef Fujimori M, Uchitomi Y (2009) Preferences of cancer patients regarding communication of bad news: a systematic literature review. Jpn J Clin Oncol 39:201–216PubMedCrossRef
11.
Zurück zum Zitat Adams E, Boulton M, Watson E (2009) The information needs of partners and family members of cancer patients: a systematic literature review. Patient Educ Couns 77:179–186PubMedCrossRef Adams E, Boulton M, Watson E (2009) The information needs of partners and family members of cancer patients: a systematic literature review. Patient Educ Couns 77:179–186PubMedCrossRef
12.
Zurück zum Zitat Surbone A (2006) Telling the truth to patients with cancer: what is the truth? Lancet Oncol 7:944–950PubMedCrossRef Surbone A (2006) Telling the truth to patients with cancer: what is the truth? Lancet Oncol 7:944–950PubMedCrossRef
13.
Zurück zum Zitat Panagopoulou E, Mintziori G, Montgomery A et al (2008) Concealment of information in clinical practice: is lying less stressful than telling the truth? J Clin Oncol 26:1175–1177PubMedCrossRef Panagopoulou E, Mintziori G, Montgomery A et al (2008) Concealment of information in clinical practice: is lying less stressful than telling the truth? J Clin Oncol 26:1175–1177PubMedCrossRef
14.
Zurück zum Zitat Friedrichsen M, Milberg A (2006) Concerns about losing control when breaking bad news to terminally ill patients with cancer: physicians’ perspective. J Palliat Med 9:673–682PubMedCrossRef Friedrichsen M, Milberg A (2006) Concerns about losing control when breaking bad news to terminally ill patients with cancer: physicians’ perspective. J Palliat Med 9:673–682PubMedCrossRef
15.
Zurück zum Zitat Li J (2012) New generations of Chinese doctors face crisis. Lancet 379:1878CrossRef Li J (2012) New generations of Chinese doctors face crisis. Lancet 379:1878CrossRef
16.
17.
Zurück zum Zitat Numico G, Anfossi M, Bertelli G et al (2009) The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer. Ann Oncol 20:941–945PubMedCrossRef Numico G, Anfossi M, Bertelli G et al (2009) The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer. Ann Oncol 20:941–945PubMedCrossRef
18.
Zurück zum Zitat Andruccioli J, Montesi A, Raffaeli W et al (2007) Illness awareness of patients in hospice: psychological evaluation and perception of family members and medical staff. J Palliat Med 10:741–748PubMedCrossRef Andruccioli J, Montesi A, Raffaeli W et al (2007) Illness awareness of patients in hospice: psychological evaluation and perception of family members and medical staff. J Palliat Med 10:741–748PubMedCrossRef
19.
Zurück zum Zitat Wang DC, Guo CB, Peng X et al (2011) Is therapeutic non-disclosure still possible? A study on the awareness of cancer diagnosis in China. Support Care Cancer 19:1191–1195PubMedCrossRef Wang DC, Guo CB, Peng X et al (2011) Is therapeutic non-disclosure still possible? A study on the awareness of cancer diagnosis in China. Support Care Cancer 19:1191–1195PubMedCrossRef
20.
Zurück zum Zitat Back AL, Arnold RM, Baile WF et al (2007) Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 167:453–460PubMedCrossRef Back AL, Arnold RM, Baile WF et al (2007) Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 167:453–460PubMedCrossRef
21.
Zurück zum Zitat Lind SE, DelVecchio Good MJ, Seidel S et al (1989) Telling the diagnosis of cancer. J Clin Oncol 7:583–589PubMed Lind SE, DelVecchio Good MJ, Seidel S et al (1989) Telling the diagnosis of cancer. J Clin Oncol 7:583–589PubMed
22.
Zurück zum Zitat Li J, Yuan XL, Gao XH et al (2011) Whether, when, and who to disclose bad news to patients with cancer: a survey in 150 pairs of hospitalized patients with cancer and family members in China. Psycho-Oncol. doi:10.1002/pon.1979 Li J, Yuan XL, Gao XH et al (2011) Whether, when, and who to disclose bad news to patients with cancer: a survey in 150 pairs of hospitalized patients with cancer and family members in China. Psycho-Oncol. doi:10.​1002/​pon.​1979
23.
Zurück zum Zitat Shahidi J (2010) Not telling the truth: circumstances leading to concealment of diagnosis and prognosis from cancer patients. Eur J Cancer Care 19:589–593CrossRef Shahidi J (2010) Not telling the truth: circumstances leading to concealment of diagnosis and prognosis from cancer patients. Eur J Cancer Care 19:589–593CrossRef
24.
Zurück zum Zitat Wilson TD, Wheatley T, Meyers JM et al (2000) Focalism: a source of durability bias in affective forecasting. J Pers Soc Psychol 78:821–836PubMedCrossRef Wilson TD, Wheatley T, Meyers JM et al (2000) Focalism: a source of durability bias in affective forecasting. J Pers Soc Psychol 78:821–836PubMedCrossRef
25.
Zurück zum Zitat Gilbert DT, Ebert JE (2002) Decisions and revisions: the affective forecasting of changeable outcomes. J Pers Soc Psychol 82:503–514PubMedCrossRef Gilbert DT, Ebert JE (2002) Decisions and revisions: the affective forecasting of changeable outcomes. J Pers Soc Psychol 82:503–514PubMedCrossRef
26.
Zurück zum Zitat Valizadeh L, Zamanzadeh V, Rahmani A et al (2012) Cancer disclosure: experiences of Iranian cancer patients. Nurs Health Sci 14:250–256PubMedCrossRef Valizadeh L, Zamanzadeh V, Rahmani A et al (2012) Cancer disclosure: experiences of Iranian cancer patients. Nurs Health Sci 14:250–256PubMedCrossRef
27.
Zurück zum Zitat Baile WF, Buckman R, Lenzi R et al (2000) SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5:302–311PubMedCrossRef Baile WF, Buckman R, Lenzi R et al (2000) SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5:302–311PubMedCrossRef
28.
Zurück zum Zitat Rabow MW, McPhee SJ (1999) Beyond breaking bad news: how to help patients who suffer. West J Med 171:260–263PubMed Rabow MW, McPhee SJ (1999) Beyond breaking bad news: how to help patients who suffer. West J Med 171:260–263PubMed
29.
Zurück zum Zitat Chiu LQ, Lee WSD, Gao F et al (2006) Cancer patients’ preferences for communication of unfavourable news: an Asian perspective. Support Care Cancer 14:818–824PubMedCrossRef Chiu LQ, Lee WSD, Gao F et al (2006) Cancer patients’ preferences for communication of unfavourable news: an Asian perspective. Support Care Cancer 14:818–824PubMedCrossRef
30.
Zurück zum Zitat Helft PR, Petronio S (2007) Communication pitfalls with cancer patients: “hit-and-run” deliveries of bad news. J Am Coll Surgeons 205:807–811CrossRef Helft PR, Petronio S (2007) Communication pitfalls with cancer patients: “hit-and-run” deliveries of bad news. J Am Coll Surgeons 205:807–811CrossRef
31.
Zurück zum Zitat Surbone A (2006) Communication preferences and needs of cancer patients: the importance of content. Support Care Cancer 14:789–791PubMedCrossRef Surbone A (2006) Communication preferences and needs of cancer patients: the importance of content. Support Care Cancer 14:789–791PubMedCrossRef
32.
Zurück zum Zitat Parker PA, Baile WF, de Moor C et al (2001) Breaking bad news about cancer: patients’ preferences for communication. J Clin Oncol 19:2049–2056PubMed Parker PA, Baile WF, de Moor C et al (2001) Breaking bad news about cancer: patients’ preferences for communication. J Clin Oncol 19:2049–2056PubMed
33.
Zurück zum Zitat Oken D (1961) What to tell cancer patients—a study of medical attitudes. JAMA 175:1120–1128PubMedCrossRef Oken D (1961) What to tell cancer patients—a study of medical attitudes. JAMA 175:1120–1128PubMedCrossRef
34.
Zurück zum Zitat Novack DH, Plumer R, Smith RL et al (1979) Changes in physicians’ attitudes toward telling the cancer patient. JAMA 241:897–900PubMedCrossRef Novack DH, Plumer R, Smith RL et al (1979) Changes in physicians’ attitudes toward telling the cancer patient. JAMA 241:897–900PubMedCrossRef
Metadaten
Titel
When clinicians telling the truth is de facto discouraged, what is the family’s attitude towards disclosing to a relative their cancer diagnosis?
verfasst von
Dian-can Wang
Xin Peng
Chuan-bin Guo
Yan-jie Su
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1629-y

Weitere Artikel der Ausgabe 4/2013

Supportive Care in Cancer 4/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.